285 related articles for article (PubMed ID: 16306595)
1. Novel caprine adeno-associated virus (AAV) capsid (AAV-Go.1) is closely related to the primate AAV-5 and has unique tropism and neutralization properties.
Arbetman AE; Lochrie M; Zhou S; Wellman J; Scallan C; Doroudchi MM; Randlev B; Patarroyo-White S; Liu T; Smith P; Lehmkuhl H; Hobbs LA; Pierce GF; Colosi P
J Virol; 2005 Dec; 79(24):15238-45. PubMed ID: 16306595
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus (AAV) capsid genes isolated from rat and mouse liver genomic DNA define two new AAV species distantly related to AAV-5.
Lochrie MA; Tatsuno GP; Arbetman AE; Jones K; Pater C; Smith PH; McDonnell JW; Zhou SZ; Kachi S; Kachi M; Campochiaro PA; Pierce GF; Colosi P
Virology; 2006 Sep; 353(1):68-82. PubMed ID: 16806384
[TBL] [Abstract][Full Text] [Related]
3. Cloning and characterization of a bovine adeno-associated virus.
Schmidt M; Katano H; Bossis I; Chiorini JA
J Virol; 2004 Jun; 78(12):6509-16. PubMed ID: 15163744
[TBL] [Abstract][Full Text] [Related]
4. Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein.
Mori S; Wang L; Takeuchi T; Kanda T
Virology; 2004 Dec; 330(2):375-83. PubMed ID: 15567432
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of caprine adeno-associated virus (AAV-Go.1) reveals striking similarity to human AAV5.
Qiu J; Cheng F; Pintel D
Virology; 2006 Dec 5-20; 356(1-2):208-16. PubMed ID: 16926042
[TBL] [Abstract][Full Text] [Related]
6. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
7. Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer.
Kwon I; Schaffer DV
Pharm Res; 2008 Mar; 25(3):489-99. PubMed ID: 17763830
[TBL] [Abstract][Full Text] [Related]
8. AAV capsid structure and cell interactions.
Agbandje-McKenna M; Kleinschmidt J
Methods Mol Biol; 2011; 807():47-92. PubMed ID: 22034026
[TBL] [Abstract][Full Text] [Related]
9. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors.
Chao H; Liu Y; Rabinowitz J; Li C; Samulski RJ; Walsh CE
Mol Ther; 2000 Dec; 2(6):619-23. PubMed ID: 11124063
[TBL] [Abstract][Full Text] [Related]
10. Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy.
Yang L; Li J; Xiao X
Methods Mol Biol; 2011; 709():127-39. PubMed ID: 21194025
[TBL] [Abstract][Full Text] [Related]
11. Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors.
Sandalon Z; Bruckheimer EM; Lustig KH; Rogers LC; Peluso RW; Burstein H
J Virol; 2004 Nov; 78(22):12355-65. PubMed ID: 15507622
[TBL] [Abstract][Full Text] [Related]
12. Utility of PEGylated recombinant adeno-associated viruses for gene transfer.
Le HT; Yu QC; Wilson JM; Croyle MA
J Control Release; 2005 Nov; 108(1):161-77. PubMed ID: 16125817
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus serotypes: vector toolkit for human gene therapy.
Wu Z; Asokan A; Samulski RJ
Mol Ther; 2006 Sep; 14(3):316-27. PubMed ID: 16824801
[TBL] [Abstract][Full Text] [Related]
14. Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization.
Lochrie MA; Tatsuno GP; Christie B; McDonnell JW; Zhou S; Surosky R; Pierce GF; Colosi P
J Virol; 2006 Jan; 80(2):821-34. PubMed ID: 16378984
[TBL] [Abstract][Full Text] [Related]
15. Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells.
Nicklin SA; Buening H; Dishart KL; de Alwis M; Girod A; Hacker U; Thrasher AJ; Ali RR; Hallek M; Baker AH
Mol Ther; 2001 Sep; 4(3):174-81. PubMed ID: 11545607
[TBL] [Abstract][Full Text] [Related]
16. Coevolution of Adeno-associated Virus Capsid Antigenicity and Tropism through a Structure-Guided Approach.
Havlik LP; Simon KE; Smith JK; Klinc KA; Tse LV; Oh DK; Fanous MM; Meganck RM; Mietzsch M; Kleinschmidt J; Agbandje-McKenna M; Asokan A
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669336
[TBL] [Abstract][Full Text] [Related]
17. Bat adeno-associated viruses as gene therapy vectors with the potential to evade human neutralizing antibodies.
Li Y; Li J; Liu Y; Shi Z; Liu H; Wei Y; Yang L
Gene Ther; 2019 Jun; 26(6):264-276. PubMed ID: 31110296
[TBL] [Abstract][Full Text] [Related]
18. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
[TBL] [Abstract][Full Text] [Related]
19. Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure.
Moskalenko M; Chen L; van Roey M; Donahue BA; Snyder RO; McArthur JG; Patel SD
J Virol; 2000 Feb; 74(4):1761-6. PubMed ID: 10644347
[TBL] [Abstract][Full Text] [Related]
20. Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice.
Scallan CD; Jiang H; Liu T; Patarroyo-White S; Sommer JM; Zhou S; Couto LB; Pierce GF
Blood; 2006 Mar; 107(5):1810-7. PubMed ID: 16249376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
